ADMA

Conviction 14HealthcareScan · Thu, Jun 25, 2026

Gravestone doji

ADMA$8.73+0.29%

ResistanceSupportVol 14Insider buy

Vol MA14 4.01M

Mar 26Apr 14May 1May 19Jun 8Jun 25

ADMA BIOLOGICS, INC.BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)www.admabiologics.com ↗

Price8.73

Change+0.29%

Gap+0.52%

Rel volume1.72×

Avg volume3.7M

Avg $ vol30.62M

SMA 208.24

SMA 509.05

SMA 20014.16

Price vs 50-3.60%

Price vs 200-38.38%

MA stackbearish

50/200 cross—

Supertrenddown · 8.81

RSI (14)54

MACD hist0.14

MACD cross—

Stoch %K / %D73 / 80

ADX (14)20

+DI / −DI27 / 17

RSI divergence—

MACD divergence—

ATR %+4.34%

ADR %3.90%

52w high20.38

52w low7.60

From 52w high-57.19%

Above 52w low+14.80%

New 52w highNo

SqueezeOff

Bollinger width15.92%

%B0.87

Donchian pos80.19%

Donchian high9.04

Donchian low7.45

AVWAP (52w high)11.58

vs AVWAP high-24.67%

AVWAP (52w low)9.19

vs AVWAP low-5.11%

OBV trendUp

Chaikin MF (20)-0.20

Today vs 20d1.72×

Avg vol (14d)4.01M

Avg vol (20d)3.7M

Avg $ vol (20d)30.62M

Market cap2.02B

RS 3m (vs SPY)-35.47%

RS 6m (vs SPY)-63.30%

RS line new highNo

Trend template0/8

Technical rank28.3

1 week+3.62%

1 month+7.06%

3 months-9.40%

6 months-56.11%

1 year-51.12%

YTD-51.20%

P/E13.76

P/B5.18

P/S3.96

P/FCF72.69

EPS0.6000

Div yield—

ROE37.64%

ROA22.09%

Debt/Eq0.50

Current6.95

EV/EBITDA10.43

Gross margin57.39%

Net margin28.80%

Rev growth19.63%

EPS growth-25.67%

Price target19.67

Target upside125.44%

Analyst ratingBuy

Institutional99.76%

Ent. value2.08B

Revenue114.49M

Net income45.33M

Gross profit80.75M

Free cash flow27.82M

IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

ExchangeNasdaq

Shares out—

Employees647

ListedThu, Oct 17, 2013

Free float225.91M

Float %97.5%

Short interest19.9M

Days to cover6.0d

Short volume52.9%

Squeeze score62 / 100

Next earningsWed, Aug 5, 2026 (41d)

EPS forecast$0.16 · 1 est

Last EPS vs est$0.19

Last surprise—

Setup gradeD

Conviction14 / 100

Pattern quality—

Tech rank28.3 / 100

Group rank50 / 100

Status lane—

Setup direction—

Pattern family

Resistance—

Support—

Days since event—

Candle confirmGravestone doji

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in ADMA

All disclosures →

No recent disclosed trades by Congress in ADMA. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in ADMA · 3 buys

Insider	Side	Shares	Value	Traded	Filed
Grossman Jerrold B Director · Common Stock · 2026-05-27	Other	—	—	2026-05-27	2026-05-28
Grossman Jerrold B Director · Common Stock · 2026-05-27	Buy	6.4K	$51K	2026-05-27	2026-05-28
Grossman Jerrold B Director · Common Stock · 2026-05-12	Other	—	—	2026-05-12	2026-05-14
Grossman Jerrold B Director · Common Stock · 2026-05-12	Buy	12.5K	$100K	2026-05-12	2026-05-14
Grossman Jerrold B Director · Common Stock · 2026-05-11	Other	—	—	2026-05-11	2026-05-12
Grossman Jerrold B Director · Common Stock · 2026-05-11	Buy	12.5K	$100K	2026-05-11	2026-05-12

SEC filings

EDGAR filings in ADMA · 1 recent

EDGAR →

8-K8-KTue, Jun 2, 2026

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.

Start free — 7-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.